Wird geladen...

Safety and efficacy of hydroxyurea in children and adolescents with sickle/beta-thalassemia: two-year experience

BACKGROUND: Hydroxyurea is a cytotoxic and myelosuppressive drug that has been used during recent years in the treatment of children with severe sickle cell disease. Nevertheless, questions remain regarding its role in young patients with no severe course, like sickle/beta-thalassemia (S/b-thal) pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hippokratia
Hauptverfasser: Papadopoulou, E, Teli, A, Theodoridou, S, Gompakis, N, Economou, M
Format: Artigo
Sprache:Inglês
Veröffentlicht: SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL" 2015
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4938110/
https://ncbi.nlm.nih.gov/pubmed/27418768
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!